As of Aug 24
| +0.04 / +1.75%|
The 5 analysts offering 12-month price forecasts for Genesis Healthcare Inc have a median target of 2.25, with a high estimate of 3.00 and a low estimate of 1.50. The median estimate represents a -3.02% decrease from the last price of 2.32.
The current consensus among 6 polled investment analysts is to Hold stock in Genesis Healthcare Inc. This rating has held steady since August, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.